Table 1 Individual patient characteristics.
Case | Stage | Mutation type | Mutated | Sex/Age | Smoking | Pathological | Neoadjuvant | Adjuvant | First-line treatment | Response |
---|---|---|---|---|---|---|---|---|---|---|
exons | status | subtype | ||||||||
1 | IV | G719S+L861Q | 18, 21 | 70/F | Never | Acinar | None | Cisplatinā+āGemcitabine | Gefitinib | PR |
2 | Ia | 709ET=>D | 18 | 51/F | Never | MIA | None | None | None | N/A |
3 | IIIa | 709ET=>D | 18 | 43/M | Ever | Acinar | None | Cisplatinā+āDocetaxel | Cisplatinā+āGemcitabine | PD |
4 | Ia | G719A | 18 | 71/F | Never | Lepidic | None | None | None | N/A |
5 | Ib | F723I+L858R | 18, 21 | 58/F | Never | Acinar | None | None | Fluorouracil | N/A |
6 | IIIa | V689L+L858R | 18, 21 | 43/F | Never | Papillar | None | Cisplatinā+āVinorelbine | Radiotherapy | PD |
7 | Ib | G719A+I768S | 18, 20 | 77/F | Never | Lepidic | None | None | None | N/A |
8 | Ib | G719S+del746ELREA | 18, 19 | 60/F | Never | Acinar | None | None | None | N/A |
9 | IIIa | G719A | 18 | 84/M | Never | Acinar | None | None | None | N/A |
10 | IIIa | E709K+G719S | 18 | 54/F | Never | Acinar | None | Cisplatinā+āGemcitabine | None | N/A |
11 | IIIb | G719A | 18 | 64/M | Ever | Papillar | None | Cisplatinā+āVinorelbine | Cisplatinā+āGemcitabine | PD |
12 | Ib | G719A+L861Q | 18, 21 | 74/F | Never | Acinar | None | None | None | N/A |
13 | IIIa | L692V+L858R | 18, 21 | 63/F | Never | Acinar | Cisplatinā+āGemcitabine | Carboplatinā+āGemcitabine | None | PR |
14 | IIIa | G719C+S768I | 18, 20 | 77/M | Ever | Papillar | None | Cisplatinā+āGemcitabine | None | N/A |
15 | IIIa | G719S+T790M | 18, 20 | 66/F | Never | Solid | None | None | Carboplatinā+āGemcitabine | PR |
16 | Ia | G719A+S768I | 18, 20 | 62/F | Never | Lepidic | None | None | None | N/A |
17 | Ia | E709K+L858R | 18, 21 | 53/F | Never | Acinar | None | None | None | N/A |
18 | IV | E709K+G719C | 18 | 46/F | Never | Acinar | None | Cisplatinā+āGemcitabine | Cisplatinā+āPemetrexed | PD |
19 | Ia | 709ET=>D | 18 | 38/F | Never | Acinar | None | None | None | N/A |
20 | Ia | Q701L+L858R | 18, 21 | 64/F | Never | Acinar | None | None | None | N/A |
21 | Ia | G724S+S768I | 18, 20 | 47/F | Never | Papillar | None | Cisplatinā+āPemetrexed | Cisplatinā+āDocetaxel | SD |
22 | IIIa | 709ET=>D | 18 | 47/F | Never | Solid | None | None | Carboplatinā+āGemcitabine | PD |
23 | Ia | E709K+L858R | 18, 21 | 58/F | Never | Papillar | None | None | Gefitinib | PR |
24 | IV | E709A+G719E | 18 | 67/F | Never | Acinar | None | None | None | N/A |
25 | Ia | G719S | 18 | 84/F | Never | Papillar | None | None | Cisplatinā+āGemcitabine | SD |
26 | Ia | G719C+S768I | 18, 20 | 57/M | Never | Acinar | None | None | None | N/A |
27 | IIa | G719S+S768I | 18, 20 | 64/F | Never | Solid | None | Carboplatinā+āGemcitabine | None | N/A |
28 | Ia | E709A+G719S | 18 | 74/F | Never | Papillar | None | None | None | N/A |
29 | IIa | G719A | 18 | 57/M | Ever | Acinar | None | None | None | N/A |
30 | Ia | I706T+L861Q | 18, 21 | 59/F | Never | MIA | None | None | None | N/A |
31 | Ia | G719C+S768I | 18, 20 | 54/M | Ever | Lepidic | None | None | None | N/A |
32 | Ia | G719C+S768I | 18, 20 | 57/F | Never | Acinar | None | None | None | N/A |
33 | IIa | G719A | 18 | 61/F | Never | Solid | Cisplatinā+āPemetrexed | None | None | SD |
34 | Ib | E709K+K757R | 18, 19, | 68/F | Never | Papillar | None | None | None | N/A |
Ā | Ā | +L858R | 21 | Ā | Ā | Ā | Ā | Ā | Ā | Ā |